Drugs for Anaplastic Oligodendroglioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 257)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Donepezil |
Approved |
Phase 3 |
|
120014-06-4 |
3152 |
Synonyms:
( inverted exclamation markA)-E 2020
120014-06-4
1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC1L1FAE
AC-6969
AKOS000277311
Aricept
Aricept odt
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
|
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilium oxalate trihydrate
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum_001664
Spectrum5_001662
TL8000531
UNII-8SSC91326P
|
|
2 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 3 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-phenethyl-4-N-propionylanilinopiperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
Cephalon brand OF fentanyl buccal oravescent
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
fentanyl
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl [INN:BAN]
Fentanyl CII
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
Fentanyl-50
|
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
Fentora
HSDB 3329
IONSYS
Janssen pharmaceutica brand OF fentanyl
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
Nasalfent
NCGC00168252-01
N-phenethyl-4-(N-propionylanilino)piperidine
N-Phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Transmucosal oral fentanyl citrate
UNII-UF599785JZ
|
|
3 |
|
Vincristine |
Approved, Investigational |
Phase 3 |
|
57-22-7, 2068-78-2 |
5978 |
Synonyms:
22-Oxovincaleukoblastin
22-Oxovincaleukoblastine
28379-27-3
57-22-7
AC1L1LJC
C07204
C46H56N4O10
CCRIS 5763
Cellcristin
CHEBI:28445
CID5978
Citomid
D08679
DB00541
EINECS 200-318-1
Farmistin
HMS2090E19
HSDB 3199
Indole alkaloid
LCR
Leurocristine
Lilly 37231 (1:1 sulfate salt)
Liposomal Vincristine
LS-228
Marqibo
NCGC00163700-01
NCI60_026703
NCI-C04864
NSC-67574
Onco TCS
Oncovin
Oncovin (1:1 sulfate salt)
Oncovine
Onkocristin
|
PFS, Vincasar
Sulfate, vincristine
Tecnocris
Tecnocris (TN)
UNII-5J49Q6B70F
VCR
VIN
Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine
Vincasar
Vincasar (1:1 sulfate salt)
Vincasar PFS
Vincrex
Vincrex (1:1 sulfate salt)
Vincristin
Vincristin bristol
Vincristin medac
Vincristina
Vincristina [DCIT]
vincristine
Vincristine
Vincristine (INN)
Vincristine [INN:BAN]
Vincristine sulfate
Vincristine Sulfate
Vincristine Sulfate PFS
Vincristinum
Vincristinum [INN-Latin]
Vincrisul
Vincrstine
Vincrystine
Vinkristin
Vintec
Z-D-Val-lys(Z)-OH
Z-D-Val-Lys(Z)-OH
|
|
4 |
|
Lomustine |
Approved, Investigational |
Phase 3 |
|
13010-47-4 |
3950 |
Synonyms:
(Chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea
(Cloro-2-etil)-1-cicloesil-3-nitrosourea
(Cloro-2-etil)-1-cicloesil-3-nitrosourea [Italian]
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea [Chloroethyl nitrosoureas]
1-(2-chloroethyl)-3-cyclohexylnitrosourea
1-(2-Chloroethyl)-3-cyclohexylnitrosourea
13010-47-4
AC-10564
AC1L1H2T
AI3-52779
Belustine
Bristol myers squibb brand OF lomustine
Bristol Myers Squibb Brand of Lomustine
Bristol-myers squibb brand OF lomustine
Bristol-Myers Squibb Brand of Lomustine
BRN 2125058
C9H16ClN3O2
CCNU
CCNU [Chloroethyl nitrosoureas]
CCRIS 860
Cecenu
CeeNU
CeeNU (TN)
CeeNU, CCNU, Lomustine
CHEMBL514
Chloroethylcyclohexylnitrosourea
CID3950
CINU
Cyclohexyl chloroethyl nitrosourea
D00363
D008130
DB01206
EINECS 235-859-2
FT-0083566
HMS2090A17
HSDB 6519
I06-0087
|
ICIG 1109
Lomustina
Lomustina [INN-Spanish]
lomustine
Lomustine
Lomustine (USAN/INN)
Lomustine [USAN:BAN:INN]
Lomustine medac brand
Lomustine medac Brand
Lomustinum
Lomustinum [INN-Latin]
LS-728
medac Brand of Lomustine
Medac brand OF lomustine
MolPort-001-768-818
N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea
N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea
N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea
NCGC00167466-01
NCI60_041743
NCI-C04740
NCIMech_000220
NPFAPI-06
NSC 79037
NSC79037
NSC-79037
OR5087
RB 1509
Rhone Poulenc Rorer Brand of Lomustine
Rhône poulenc rorer brand OF lomustine
Rhone-Poulenc Rorer Brand of Lomustine
Rhône-poulenc rorer brand OF lomustine
S1840_Selleck
SRI 2200
UNII-7BRF0Z81KG
WLN: L6TJ AMVNNO&2G
ZINC03831006
|
|
5 |
|
Temozolomide |
Approved, Investigational |
Phase 3 |
|
85622-93-1 |
5394 |
Synonyms:
3,4-dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide
3,4-dihydro-3-Methyl-4-oxoimidazo(5,1-D)-1,2,3,5-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide
3,4-dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide
3,4-dihydro-3-Methyl-4-oxoimidazo(5,1-D)-as-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide
3-methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-D)(1,2,3,5)tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide
3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
85622-93-1
8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
8-Carbamoyl-3-methylimidazo(5,1-D)-1,2,3,5-tetrazin-4(3H)-one
AC1L1K9B
AC-758
BIDD:GT0204
Bio-0147
BRN 5547136
C047246
C6H6N6O2
CCRG 81045
CCRG-81045
CCRIS 8996
CHEBI:153686
CHEMBL810
CID5394
CPD000466338
D06067
DB00853
Essex brand of temozolomide
HMS2051O12
HMS2090B08
I06-0149
I14-1943
LS-80558
M B 39831
m & b 39831
M & B 39831
m And b 39831
m And b-39831
|
M&B 39831
M&B-39831
M-39831
MB 39831
Methazolastone
MLS000759447
MLS001424028
MLS002701861
NCGC00167429-01
NCGC00167429-02
NCI60_003316
NSC 362856
NSC362856
NSC-362856
SAM001246636
Sch 52365
SCH 52365
Sch-52365
Schering brand of temozolomide
Schering-Plough brand of temozolomide
SMR000466338
STK623541
Temodal
Temodal (TN)
Temodar
Temozolamide
Temozolodida
Temozolodida [Spanish]
Temozolomid
Temozolomida
temozolomide
Temozolomide
Témozolomide
Temozolomide (JAN/USAN/INN)
Temozolomide [INN:BAN]
Temozolomidum
Temozolomidum [Latin]
TL8005593
TMZ
TMZ-Bioshuttle
UNII-YF1K15M17Y
ZINC01482184
|
|
6 |
|
Methylphenidate |
Approved, Investigational |
Phase 3 |
|
113-45-1 |
4158 |
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
298-59-9 (hydrochloride)
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
4311/B Ciba
AC1L1HJM
alpha-Phenyl-2-piperidineacetate methyl ester
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
a-Phenyl-2-piperidineacetate methyl ester
a-Phenyl-2-piperidineacetic acid methyl ester
C 4311
C07196
Calocain
Celltech brand OF methylphenidate hydrochloride
Centedein
Centedrin
Centedrine
Centredin
Cephalon brand OF methylphenidate hydrochloride
CHEBI:6887
CHEMBL796
CID4158
Concerta
D04999
Daytrana
Daytrana (TN)
DB00422
DB06701
DEA No. 1724
d-methylphenidate HCl
D-Methylphenidate HCL
EINECS 204-028-6
Equasym
Focalin
Focalin XR
HSDB 3126
Hydrochloride, methylphenidate
L001307
LS-565
Mallinckrodt brand OF methylphenidate hydrochloride
Meridil
Metadate
Metadate CD
Metadate ER
Methyl (2-phenyl-2-(2-piperidyl)acetate)
methyl 2-phenyl-2-piperidin-2-ylacetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetic acid
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl alpha-phenyl-alpha-2-piperidinylacetic acid
Methyl a-phenyl-a-(2-piperidyl)acetate
Methyl a-phenyl-a-(2-piperidyl)acetic acid
Methyl a-phenyl-a-2-piperidinylacetate
Methyl a-phenyl-a-2-piperidinylacetic acid
Methyl phenidate
|
Methyl phenidyl acetate
Methyl phenidylacetate
Methyl phenidylacetic acid
methyl phenyl(piperidin-2-yl)acetate
methyl α-phenyl-α-(2-piperidyl)acetate
Methyl α-phenyl-α-(2-piperidyl)acetate
Methyl α-phenyl-α-(2-piperidyl)acetic acid
methyl α-phenyl-α-2-piperidinylacetate
Methyl α-phenyl-α-2-piperidinylacetate
Methyl α-phenyl-α-2-piperidinylacetic acid
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
methylphenidate
Methylphenidate
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
Methylphenidate (USAN/INN)
Methylphenidate [INN:BAN]
Methylphenidate HCl
Methylphenidate HCL
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidic acid
Methylphenidylacetate hydrochloride
Methypatch
MethyPatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
MPH
nchembio.2007.55-comp28
NCI-C56280
Novartis brand 1 OF methylphenidate hydrochloride
Novartis brand 2 OF methylphenidate hydrochloride
Phenidylate
Plimasine
PMS-Methylphenidate
Riphenidate
Ritalin
Ritalin hydrochloride
Ritalin LA
Ritalin SR
Ritaline
Ritalin-SR
Ritcher works
Ritcher Works
Tsentedrin
UNII-207ZZ9QZ49
α-phenyl-2-piperidineacetate methyl ester
α-phenyl-2-piperidineacetic acid methyl ester
|
|
7 |
|
Dopamine |
Approved |
Phase 3 |
|
51-61-6, 62-31-7 |
681 |
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
8 |
|
Histamine |
Approved, Investigational |
Phase 3 |
|
51-45-6 |
774 |
Synonyms:
1H-Imidazole-4-ethanamine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-imidazolyl)ethylamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-imidazoleethylamine
4-Imidazoleethylamine
5-imidazoleethylamine
5-Imidazoleethylamine
beta-aminoethylglyoxaline
beta-Aminoethylglyoxaline
beta-aminoethylimidazole
|
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Ceplene
Dihydrochloride, histamine
Eramin
Ergamine
Ergotidine
Free histamine
Histamine dihydrochloride
Histamine hydrochloride
HSM
Hydrochloride, histamine
L-Histamin base
L-Histamine
Peremin
Theramine
|
|
9 |
|
Cyproheptadine |
Approved |
Phase 3 |
|
129-03-3 |
2913 |
Synonyms:
129-03-3
1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine
1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine
1-Methyl-4-(5H-dibenzo(a,D)cycloheptenylidene)piperidine
4-(5-dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine
4-(5-dibenzo(a,D)Cyclohepten-5-ylidine)-1-methylpiperidine
4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene
4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-dibenzo(a,D)Cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine
41354-29-4
4-dibenzo[a,D]Cyclohepten-5-ylidene-1-methyl-piperidine
4-Dibenzo[a,d]cyclohepten-5-ylidene-1-methyl-piperidine
5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene
5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene
5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,D)cyclopheptene
5-20-08-00500 (Beilstein Handbook Reference)
AC1L1ER8
AKOS004119847
Antergan
BIDD:GT0324
Biomol-NT_000131
BPBio1_000096
BPBio1_000155
BRD-K28143534-001-01-4
BRD-K28143534-003-03-6
BRN 1685976
BSPBio_000086
C06935
CAS-969-33-5
CCRIS 5232
CHEBI:4046
CHEMBL516
CID2913
Ciproheptadina
Ciproheptadina [INN-Spanish]
Ciprovit
Ciprovit (TN)
Cypoheptadine
Cyproheptadiene
Cyproheptadin
Cyproheptadine
|
CYPROHEPTADINE
Cyproheptadine (INN)
Cyproheptadine [INN:BAN]
Cyproheptadine Hcl
Cyproheptadinum
Cyproheptadinum [INN-Latin]
D07765
DB00434
Dibenzosuberonone/Cyproheptadine
Dihexazin
Dronactin
EINECS 204-928-9
Eiproheptadine
HMS2090P20
HSDB 3048
L001016
Lopac0_000246
Lopac-C-6022
LS-114933
MK 141
MolPort-002-507-777
NCGC00015252-01
NCGC00015252-02
NCGC00015252-03
NCGC00015252-09
NCGC00024293-02
NCGC00024293-04
NCGC00024293-05
nchembio.559-comp10
Oprea1_498140
PDSP1_001229
PDSP2_001213
Periactin
Periactine
Periactinol
Peritol
Prestwick0_000103
Prestwick1_000103
Prestwick2_000103
Prestwick3_000103
SPBio_002025
STK802098
Tocris-0996
UNII-2YHB6175DO
Viternum
|
|
10 |
|
Pancreatic Polypeptide |
Investigational |
Phase 3 |
|
59763-91-6 |
|
11 |
|
Anesthetics |
|
Phase 3 |
|
|
|
12 |
|
Analgesics |
|
Phase 3 |
|
|
|
13 |
|
Cholinesterase Inhibitors |
|
Phase 3 |
|
|
|
14 |
|
Cholinergic Agents |
|
Phase 3 |
|
|
|
15 |
|
Liver Extracts |
|
Phase 3 |
|
|
|
16 |
|
Cola |
|
Phase 3 |
|
|
|
17 |
|
Narcotics |
|
Phase 3 |
|
|
|
18 |
|
Analgesics, Opioid |
|
Phase 3 |
|
|
|
19 |
|
Anesthetics, General |
|
Phase 3 |
|
|
|
20 |
|
Anesthetics, Intravenous |
|
Phase 3 |
|
|
|
21 |
|
Tubulin Modulators |
|
Phase 3 |
|
|
|
22 |
|
Antimitotic Agents |
|
Phase 3 |
|
|
|
23 |
|
Alkylating Agents |
|
Phase 3 |
|
|
|
24 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
25 |
|
Central Nervous System Stimulants |
|
Phase 3 |
|
|
|
26 |
|
Dopamine Agents |
|
Phase 3 |
|
|
|
27 |
|
Dexmethylphenidate Hydrochloride |
|
Phase 3 |
|
|
|
28 |
|
Histamine Antagonists |
|
Phase 3 |
|
|
|
29 |
|
Anti-Allergic Agents |
|
Phase 3 |
|
|
|
30 |
|
Histamine Phosphate |
|
Phase 3 |
|
51-74-1 |
65513 |
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
|
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
|
|
31 |
|
Histamine H1 Antagonists |
|
Phase 3 |
|
|
|
32 |
|
Gastrointestinal Agents |
|
Phase 3 |
|
|
|
33 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 3 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
Antemovis
|
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
Serotonine
sérotonine
thrombocytin
Thrombocytin
thrombotonin
Thrombotonin
|
|
34 |
|
Ethanol |
Approved |
Phase 1, Phase 2 |
|
64-17-5 |
702 |
Synonyms:
(C6-C9)Alkyl alcohol
[CH2Me(OH)]
[OEtH]
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
1-Hydroxyethane
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
absolute alcohol
Absolute alcohol
Absolute Alcohol
Absolute ethanol
Absolute Ethanol
Absolute ethyl alcohol
AC1L19TW
AC1Q31MM
Aethanol
Aethanol [German]
Aethylalkohol
AHD 2000
AI3-01706
Alcare hand degermer
Alcare Hand Degermer
alcohol
Alcohol
Alcohol (ethyl)
Alcohol (USP)
Alcohol [USP]
ALCOHOL 5% IN D5-W
Alcohol anhydrous
Alcohol Anhydrous
Alcohol dehydrated
Alcohol denatured
alcohol etilico
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Absolute
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, Dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, Diluted
Alcohol, ethyl
Alcohol, grain
Alcohol, Grain
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool ethylique
Alcool Ethylique
Alcool éthylique
Alcool etilico
Alcool Etilico
Algrain
Alkohol
Alkohol [German]
Alkoholu etylowego
Alkoholu Etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
bmse000297
C00469
C2H5OH
C2H6O
Caswell No. 426
Caswell No. 430
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
|
CHEMBL545
CID702
Colamine
Cologne spirit
Cologne Spirit
Cologne spirits
D000431
D00068
DB00898
Dehydrated alcohol
Dehydrated ethanol
Dehydrated Ethanol
Denatured alcohol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Denatured Ethanol
Desinfektol el
Desinfektol EL
Diluted alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
Envision Conditioner Pdd 9020
EOH
EOX
Esumiru WK 88
ETA
etanol
Etanol
Etanolo
Etanolo [Italian]
ethanol
éthanol
Ethanol (9CI)
Ethanol [JAN]
Ethanol 200 proof
Ethanol 200 Proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol Vapor
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl alc
ethyl alcohol
Ethyl alcohol
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl Alcohol Anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl Hydrate
Ethyl hydroxide
Ethyl Hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
EtOH
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
grain alcohol
Grain alcohol
Hinetoless
HSDB 531
HSDB 82
Hydroxyethane
HYDROXYETHYL GROUP
I14-12648
IMS 99
Infinity pure
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated spirit
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
MolPort-001-785-844
NCGC00091458-01
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
potato Alcohol
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spirits OF wine
spiritus vini
Spiritus vini
Spirt
SY Fresh M
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
UNII-3K9958V90M
USAF EK-1597
WLN: Q2
|
|
35 |
|
Capecitabine |
Approved, Investigational |
Phase 2 |
|
154361-50-9 |
60953 |
Synonyms:
(1-(5-Deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester
(1-(5-Deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
(1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester
(1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
154361-50-9
158798-73-3
5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
AC1L1U83
AC1Q4KU8
Ambap154361-50-9
C110904
C12650
C15H22FN3O6
CAPE
Capecitabin
capecitabina
Capecitabina
capecitabine
Capecitabine
CAPECITABINE
Capécitabine
Capecitabine (JAN/USAN/INN)
Capecitabine [USAN]
capecitabinum
Capecitabinum
Capecitibine
Capiibine
Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester
Caxeta
CHEBI:31348
CHEMBL1773
CID60953
|
D01223
DB01101
FT-0082472
HSDB 7656
LS-59070
MolPort-005-938-254
N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Pentyl [1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
Pentyl [1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid
Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid
Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid
Pentyl 1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
Pentyl 1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid
Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid
pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
Pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
Pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid
pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
R340
R-340
RG-340
Ro 09-1978
Ro 09-1978/000
Ro-09-1978
Ro-09-1978/000
S1156_Selleck
UNII-6804DJ8Z9U
Xabine
Xeloda
Xeloda (TN)
Xeloda, Captabin, Capecitabine
ZINC03806413
|
|
36 |
|
Irinotecan |
Approved, Investigational |
Phase 2 |
|
97682-44-5, 100286-90-6 |
60838 |
Synonyms:
(+)-Irinotecan
(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE
(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate
1u65
7-Ethyl-10-hydroxycamptothecin
97682-44-5
AC1L1U0Z
AC1Q6PGI
AC-7469
Bio-0054
Biotecan
Biotecan (TN)
BRD-K08547377-003-02-4
BSPBio_002346
C16641
C33H38N4O6
Campothecin-11
Campto
Camptosar
Camptosar, Campto, CPT-11, Irinotecan
Camptothecin-11
CHEBI:105985
CHEMBL481
CID60838
CP0
CPT 11
CPT-11
D08086
DB00762
|
FT-0083650
HSDB 7607
Irinophore C
irinotecan
Irinotecan
Irinotecan (INN)
Irinotecan [INN:BAN]
Irinotecan Hcl
Irinotecan hydrochloride
Irinotecan Hydrochloride
Irinotecan hydrochloride trihydrate
Irinotecan Hydrochloride Trihydrate
IRINOTECAN HYDROCHLORIDE Trihydrate
Irinotecan lactone
Irinotecan mylan
IRINOTECAN, CPT-11
Irinotecanum
Irinotecanum [INN-Latin]
Irrinotecan
LS-44589
NCI60_005051
NK012 Compound
NSC728073
S1198_Selleck
sn 38
sn-38
sn38 CPD
TL8006026
UNII-7673326042
|
|
37 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-chloro-a,a-Diphenylbenzyl)imidazole
1-(O-chloro-alpha,alpha-Diphenylbenzyl)imidazole
1-(o-Chlorotrityl)imidazole
1-(O-Chlorotrityl)imidazole
1-(o-Chloro-α,α-diphenylbenzyl)imidazole
1-(O-chloro-α,α-diphenylbenzyl)imidazole
1-(α-(2-chlorophenyl)benzhydryl)imidazole
1-(α-(2-Chlorophenyl)benzhydryl)imidazole
117829-71-7
23593-75-1
33894_FLUKA
33894_RIEDEL
3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591
AB00051951
AC1L1EIW
AC-279
B 5097
BAY 5097
Bay b 5097
BAY b 5097
Bay b 9057
BAY b5097
BAY-5097
Bay-B 5097
BAYb 5097
Bayer brand 1 OF clotrimazole
Bayer Brand 1 of Clotrimazole
Bayer brand 2 OF clotrimazole
Bayer Brand 2 of Clotrimazole
BIDD:GT0450
BIDD:PXR0036
Bio-0442
BPBio1_000126
BRN 0622318
BSPBio_000114
BSPBio_002057
C 6019
C06922
C22H17ClN2
C6019_SIGMA
Canesten
Canesten 1-day cream combi-pak
Canesten 1-Day Cream Combi-Pak
Canesten 1-day therapy
Canesten 1-Day Therapy
Canesten 3-day therapy
Canesten 3-Day Therapy
Canesten 6-day therapy
Canesten 6-Day Therapy
Canesten combi-pak 1-day therapy
Canesten Combi-Pak 1-Day Therapy
Canesten combi-pak 3-day therapy
Canesten Combi-Pak 3-Day Therapy
Canesten cream
Canesten Cream
Canesten solution
Canesten Solution
Canestene
Canestine
Canifug
CAS-23593-75-1
CCRIS 6245
CHEBI:3764
CHEMBL104
Chlotrimazole
CID2812
Cimitidine
Clomatin
Clotrimaderm
Clotrimaderm cream
Clotrimazol
Clotrimazol [INN-Spanish]
clotrimazole
Clotrimazole
Clotrimazole (JP15/USP/INN)
Clotrimazole [USAN:INN:BAN:JAN]
Clotrimazole schering brand
Clotrimazole Schering Brand
Clotrimazolum
Clotrimazolum [INN-Latin]
clotrimeizol
CPD000058306
CPD-8926
Cutistad
D00282
D003022
DB00257
Desamix F
DivK1c_000665
DRG-0072
EINECS 245-764-8
Empecid
Esparol
EU-0100315
FB 5097
FB b 5097
Fem care
Fem Care
FemCare
Gino-Lotremine
Gyne lotrimin
Gyne-lotrimin
Gyne-Lotrimin
Gyne-lotrimin 3
Gyne-Lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-Lotrimin 3 Combination Pack
Gyne-lotrimin combination pack
Gyne-Lotrimin Combination Pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
Gynix
HMS1568F16
HMS1920O21
HMS2051E11
HMS2091G10
HMS502B07
HSDB 3266
I01-3474
IDI1_000665
|
Kanesten
KBio1_000665
KBio2_001823
KBio2_004391
KBio2_006959
KBio3_001277
KBioGR_000850
KBioSS_001823
Klotrimazole
Lopac0_000315
Lopac-C-6019
Lotrimax
Lotrimin
Lotrimin (TN)
Lotrimin af
Lotrimin Af
Lotrimin af cream
Lotrimin AF Cream
Lotrimin af jock-itch cream
Lotrimin AF Jock-Itch Cream
Lotrimin af lotion
Lotrimin AF Lotion
Lotrimin af solution
Lotrimin AF Solution
Lotrimin cream
Lotrimin Cream
Lotrimin lotion
Lotrimin Lotion
Lotrimin solution
Lotrimin Solution
Lotrisone
LS-78271
MLS000028502
MLS000758243
MLS001423972
MolPort-002-557-756
mono-Baycuten
Monobaycuten
Mono-baycuten
Mycelax
Mycelex
Mycelex (TN)
Mycelex 7
Mycelex cream
Mycelex Cream
Mycelex g
Mycelex G
Mycelex otc
Mycelex OTC
Mycelex solution
Mycelex Solution
Mycelex troches
Mycelex Troches
Mycelex twin pack
Mycelex Twin Pack
Mycelex: mycosporinrimazole
Mycelex: MycosporinRimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-7 Combination Pack
Mycelex-g
Mycelex-G
myclo Cream
Myclo Cream
myclo Solution
Myclo Solution
myclo Spray solution
Myclo Spray Solution
myclo-Gyne
Myclo-Gyne
Mycofug
Mycosporin
Mykosporin
Nalbix
NCGC00015251-01
NCGC00015251-02
NCGC00015251-03
NCGC00015251-09
NCGC00093761-01
NCGC00093761-02
NCGC00093761-03
NCGC00093761-04
NCGC00093761-05
NCGC00093761-06
nchembio.65-comp9
nchembio790-comp30
NCIMech_000609
neo-Zol cream
Neo-Zol Cream
NINDS_000665
NSC 257473
NSC257473
Otomax
Pan-Fungex
Pedisafe
Prestwick_120
Prestwick0_000267
Prestwick1_000267
Prestwick2_000267
Prestwick3_000267
QTL1_000024
Rimazole
S1606_Selleck
SAM001247056
Schering brand OF clotrimazole
Schering Brand of Clotrimazole
SMR000058306
SPBio_000176
SPBio_002333
Spectrum_001343
SPECTRUM1500200
Spectrum2_000128
Spectrum3_000359
Spectrum4_000295
Spectrum5_000781
Stiemazol
STK700023
Tibatin
Trimysten
Trivagizole 3
UNII-G07GZ97H65
Veltrim
ZINC03807804
|
|
38 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 1, Phase 2 |
|
22916-47-8 |
4189 |
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
Aflorix(nitrate)
AKOS001574474
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
Brentan
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
Conofite(nitrate)
CPD-4501
D00416
Dactarin
Daktarin IV
DB01110
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Esteve brand OF miconazole
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
Lotrimin AF(nitrate)
LS-78378
MCZ
Micantin (nitrate)
Miconasil nitrate
Miconasil Nitrate
Miconazol
|
Miconazol [INN-Spanish]
miconazole
Miconazole
Miconazole (JP15/USP/INN)
Miconazole [USAN:BAN:INN:JAN]
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MJR 1762
MLS002222203
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
Nitrate, miconasil
Nitrate, miconazole
Novo-Miconazole Vaginal Ovules
NSC 170986
NSC169434
NSC170986
Oprea1_091955
Prestwick_335
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
Spectrum_000965
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
STK834405
STOCK1S-93556
UNII-7NNO0D7S5M
Vusion
Zimycan
|
|
39 |
|
Bevacizumab |
Approved, Investigational |
Phase 2 |
|
216974-75-3 |
|
Synonyms:
216974-75-3
antiVEGF
Anti-VEGF Humanized Monoclonal Antibody
anti-VEGF monoclonal antibody
Anti-VEGF monoclonal antibody
Avastin
Avastin (TN)
bevacizumab
|
Bevacizumab
Bevacizumab (genetical recombination)
Bevacizumab (genetical recombination) (JAN)
bevacizumab-awwb
D06409
R-435
rhuMAb-VEGF
|
|
40 |
|
Phenobarbital |
Approved, Investigational |
Phase 1, Phase 2 |
|
50-06-6 |
4763 |
Synonyms:
11097-06-6
46755-67-3
50-06-6
57-30-7 (mono-hydrochloride salt)
5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione
5-Ethyl-5-phenylbarbitate
5-Ethyl-5-phenylbarbitic acid
5-Ethyl-5-phenylbarbituric acid
5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione
5-Phenyl-5-ethylbarbitate
5-Phenyl-5-ethylbarbitic acid
5-Phenyl-5-ethylbarbituric acid
AC1L1IWE
Acid, phenylethylbarbituric
Acido 5-fenil-5-etilbarbiturico
Acido 5-fenil-5-etilbarbiturico [Italian]
Adonal
aephe nal
Aephenal
Agrypnal
AI3-02726
AKOS000605404
Amylofene
Antrocol
Aphenylbarbit
Aphenyletten
Arco-Lase Plus
Austrominal
barbapil
barbellen
barbellon
Barbenyl
barbilehae
Barbilehae (barbilettae)
Barbinal
Barbipenyl
Barbiphen
Barbiphenyl
Barbipil
Barbita
Barbivis
Barbonal
Barbophen
Bardorm
Bartol
BAS 00226811
Bialminal
BIDD:PXR0061
Blu-phen
Blu-Phen
C07434
Cabronal
Calmetten
Calminal
Cardenal
CCRIS 502
Chardonna-2
CHEBI:8069
CHEMBL40
Chinoin
CID4763
Codibarbita
component of Antrocol
component of Bronkotabs
component of Hecadrol
component of Primatene P
component of Slowten
component of Tedral
component of Valpin 50-PB
Coronaletta
Cratecil
d ezibarbitur
D00506
Damoral
DB01174
DEA No. 2285
Dezibarbitur
DivK1c_000987
Donphen
Dormina
Dormiral
Dormital
Doscalun
Duneryl
EINECS 200-007-0
Elixir of phenobarbital
Ensobarb
Ensodorm
Epanal
Epidorm
Epilol
Episedal
Epsylone
Eskabarb
Etilfen
Euneryl
fen osed
Fenbital
Fenemal
Fenobarbital
Fenobarbital [INN-Spanish]
Fenobarbitale
Fenobarbitale [DCIT]
Fenosed
Fenylettae
Gardenal
Gardepanyl
Glysoletten
Gustase-Plus
Haplopan
Haplos
Helional
Hennoletten
Henotal
HMS503E15
HSDB 3157
Hypnaletten
Hypnette
Hypnogen
Hypnolone
Hypnoltol
Hypno-Tablinetten
Hysteps
I06-0652
IDI1_000987
InChI=1/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17
KBio1_000987
le phebar
Lefebar
Leonal
Lephebar
Lepinal
|
Lepinaletten
Levsin PB Drops and Tablets
Linasen
Liquital
Lixophen
LS-135
Lubergal
Lubrokal
Lumen
Lumesettes
Lumesyn
Luminal
Luminal (TN)
Lumofridetten
Luphenil
Luramin
MLS001240232
Molinal
MolPort-001-783-066
MolPort-003-959-166
Monosodium salt phenobarbital
NCGC00159493-02
NCGC00159493-03
Neurobarb
NINDS_000987
Nirvonal
Noptil
Nova-Pheno
NSC 128143
NSC128143
NSC9848
Nunol
Oprea1_384816
P1636_SIGMA
Pamine PB
Parkotal
Pharmetten
Phazyme-PB
Phenaemal
Phen-Bar
Phenemal
Phenemalum
Phenobal
Phenobarb
phenobarbital
Phenobarbital
Phenobarbital (JP15/USP/INN)
phenobarbital (PB)
Phenobarbital [USAN:INN:JAN]
Phenobarbital sodium
Phenobarbital, monosodium salt
Phenobarbital, Monosodium Salt
Phenobarbitalum
Phenobarbitalum [INN]
Phenobarbitalum [INN-Latin]
Phenobarbitate
Phenobarbitic acid
Phenobarbitol
phenobarbitone
Phenobarbitone
Phenobarbitonum
Phenobarbituric acid
Phenobarbituric Acid
Phenobarbyl
Phenoluric
Phenolurio
Phenomet
Phenonyl
Phenoturic
Phenylaethylbarbitursaeure
Phenyläthylbarbitursäure
Phenylbarbital
Phenylethyl barbituric acid
Phenylethylbarbitate
Phenylethylbarbitic acid
Phenylethylbarbiturate
Phenylethylbarbituric acid
Phenyl-ethyl-barbituric acid
Phenylethylbarbituric Acid
Phenylethylbarbitursaeure
Phenylethylbarbitursäure
Phenylethylmalonylurea
PHENYLETHYLMALONYLUREA
Phenyletten
phenylral
Phenyral
Phob
PHOB
Polcominal
Promptonal
PUBERTAL PHENOBARBITAL STUDY
Sedabar
seda-tabl inen
Seda-Tablinen
Sedicat
Sedizorin
Sedlyn
Sedofen
Sedonal
Sedonal (sedative)
Sedonettes
Sedophen
Sevenal
Sinoratox
SK-Phenobarbital
SMR000058986
Sodium, phenobarbital
Solfoton
Solfoton talpheno
Solfoton Talpheno
Solu-Barb
Sombutol
Somnolens
Somnoletten
Somnosan
Somonal
Spasepilin
Starifen
Starilettae
Stental
stental exte ntabs
Stental Extentabs
Talpheno
Teolaxin
Teoloxin
Thenobarbital
Theoloxin
theominal
Triabarb
Tridezibarbitur
Triphenatol
UNII-YQE403BP4D
Valprin 50-PB
Versomnal
WLN: T6VMVMV FHJ F2 FR
Zadoletten
Zadonal
|
|
41 |
|
Phenytoin |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
57-41-0 |
1775 |
Synonyms:
125-59-7
2,4-Imidazolidinedione, 5,5-diphenyl- (9CI)
2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one
5,5-Diphenyl-2,4-imidazolidinedione
5,5-diphenylhydantoin
5,5-Diphenylhydantoin
5,5-DIPHENYLHYDANTOIN
5,5-Diphenylhydantoin (IUPAC)
5,5-Diphenylhydantoin (phenytoin)
5,5-Diphenylimidazolidin-2,4-dione
5,5-diphenylimidazolidine-2,4-dione
5,5-Diphenylimidazolidine-2,4-dione
5,5-Diphenyl-imidazolidine-2,4-dione
5,5-diphenyltetrahydro-1H-2,4-imidazoledione
5,5-diphenyltetrahydro-1H-2,4-Imidazoledione
5,5-Diphenyltetrahydro-1H-2,4-imidazoledione
5,5-Dwufenylohydantoina
5,5-Dwufenylohydantoina [Polish]
57-41-0
630-93-3
AC1L1C7L
AC1Q6G55
AC1Q6G56
AC-376
AI3-52498
AKOS000416887
AKOS003245432
Aleviatin
Antisacer
Auranile
BAS 00281572
BIDD:GT0625
BIDD:PXR0090
Bio-0370
BRD-K55930204-001-02-7
BSPBio_001437
C07443
Causoin
CCRIS 515
CHEBI:8107
CHEMBL16
CID1775
Citrullamon
Citrulliamon
CL12003
Comital
Comitoina
component of Mebroin
Convul
D 4007
D00512
D0894
D4007_SIGMA
Danten
Dantinal
Dantoinal
Dantoinal klinos
Dantoine
DB00252
Denyl
Didan TDC 250
Didan-tdc-250
Difenilhidantoina
Difenilhidantoina [Spanish]
Difenin
Difetoin
Difhydan
Dihycon
Dihydan
Di-Hydan
Dihydan toin
Dihydantoin
Dilabid
Di-Lan
Di-Lan (VAN)
Dilantin
DILANTIN
Dilantin (TN)
Dilantin acid
Dilantin-125
DILANTIN-30
Dilantine
Dillantin
Dintoin
Dintoina
Diphantoin
Diphedal
Diphedan
Diphenat
Diphenin
Diphenine
Diphentoin
Diphentyn
Diphenylan
Diphenylan sodium
Diphenylan Sodium
Diphenylhydantoin
Diphenylhydantoin (VAN)
Diphenylhydantoinate, sodium
Diphenylhydantoine
Diphenylhydantoine [French]
Diphenylhydatanoin
Di-Phetine
Ditoinate
DivK1c_000507
DPH
DPH (VAN)
EINECS 200-328-6
Ekko
Ekko capsules
elepsi ndon
Elepsindon
Enkelfel
Epamin
Epanutin
Epasmir "5"
epasmir ''5''
Epasmir 5
Epdantoin Simple
Epdantoine simple
Epelin
Epifenyl
Epihydan
Epilan
Epilan D
Epilan-D
Epilantin
Epinat
Epised
Eptal
Eptoin
EU-0100378
Extended Phenytoin Sodium
fen toin
Fenantoin
Fenantoin Mn Pharma
Fenidantoin "s"
fenidantoin ''s''
Fenidantoin s
Fenitoin
Fenitoina
Fenitoina [INN-Spanish]
Fentoin
Fenylepsin
Fenytoin Dak
Fenytoine
|
Gerot-epilan-D
Hidan
Hidantal
Hidantilo
Hidantina
Hidantina senosian
Hidantina vitoria
Hidantomin
Hindatal
HMS1412J16
HMS1694O05
HMS1791H19
HMS1989H19
HMS2089E11
Hydantal
Hydantin
Hydantoin
Hydantoin, 5,5-diphenyl- (8CI)
Hydantoinal
Hydantol
I14-6452
ictalis simp le
Ictalis simple
Idantoil
Idantoin
IDI1_000507
IDI1_008433
IFLab1_000214
InChI=1/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19
Iphenylhydantoin
KBio1_000507
KBio2_001585
KBio2_004153
KBio2_006721
KBio3_001780
KBioGR_001387
KBioSS_001585
Kessodanten
Labopal
Lehydan
Lepitoin
Lepsin
Lopac0_000329
Lopac0_000378
Lopac-D-4007
LS-34
Mesantoin
Minetoin
MLS000069789
MLS001074087
MLS002454401
MolPort-001-785-683
MolPort-002-365-712
MolPort-004-876-351
NCGC00015342-01
NCGC00015342-02
NCGC00015342-04
NCGC00021139-01
NCGC00091492-01
NCGC00091492-02
NCGC00091492-03
NCGC00091492-04
NCGC00091492-05
NCGC00093810-01
NCGC00093810-02
NCI-C55765
Neos-Hidantoina
Neosidantoina
NINDS_000507
Novantoina
Novophenytoin
NSC 8722
NSC8722
Om hidantoina simple
Om-Hydantoine
Oprea1_373280
Oxylan
Park davis brand OF phenytoin
Pfizer brand OF phenytoin
Phanantin
Phanatine
phenat ine
Phenatine
Phenatoine
Phenhydan
Phenhydanin
Phenitoin
Phentoin
Phentytoin
PHENTYTOIN
PHENYTEK
Phenytex
phenytoin
Phenytoin
PHENYTOIN (5,5-DIPHENYLHYDANTOIN)
Phenytoin (JP15/USP/INN)
phenytoin (PHN)
Phenytoin [USAN:INN:BAN:JAN]
Phenytoin AWD
Phenytoin pfizer brand
Phenytoin phizer brand
Phenytoin sodium
Phenytoin Sodium
PHENYTOIN SODIUM, EXTENDED
Phenytoine
Phenytoine [INN-French]
Phenytoin-Gerot
Phenytoinum
Phenytoinum [INN-Latin]
Phizer brand OF phenytoin
Prompt Phenytoin Sodium
Ritmenal
Saceril
Sanepil
Silantin
Sinergina
SMR000059026
Sodanthon
Sodantoin
Sodanton
Sodium diphenylhydantoinate
Sodium Diphenylhydantoinate
Solantin
Solantoin
Solantyl
SPBio_001281
Spectrum_001105
Spectrum2_001281
Spectrum3_000890
Spectrum4_000984
Spectrum5_001369
STK058029
STK182871
Sylantoic
taco sal
Tacosal
Thilophenyl
TOIN
Toin unicelles
UNII-6158TKW0C5
WLN: T5MVMV EHJ ER& ER
Zentronal
Zentropil
ZINC02510358
ZINC18140189
|
|
42 |
|
Oxcarbazepine |
Approved |
Phase 1, Phase 2 |
|
28721-07-5 |
34312 |
Synonyms:
10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide
10,11-dihydro-10-oxo-5H-Dibenz(b,F)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide
10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
28721-07-5
5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
AB1004555
AC1L1RCU
AC1Q6NA8
AC-3483
BIDD:GT0078
Bio-0527
BSPBio_003457
C036006
C07492
CHEMBL1068
CID34312
CPD000048684
D00533
DB00776
Desitin brand of oxcarbazepine
Desitin brand OF oxcarbazepine
EINECS 249-188-8
Epilexter
Epliga
GP 47680
GP-47680
HMS1922H17
HMS2051O04
HMS2090F13
HMS2093E10
HSDB 7524
I06-0072
KBio2_002155
KBio2_004723
KBio2_007291
KBio3_002677
KBioGR_001248
KBioSS_002155
KIN-493
|
LS-60365
MLS000084586
MLS000759520
MLS001201742
MolPort-001-685-316
NCGC00065934-02
NCGC00065934-03
NCGC00065934-04
Novartis brand of oxcarbazepine
Novartis brand OF oxcarbazepine
O0363
O3764_SIGMA
OCBZ
Oxacarbazepine
Oxcarbamazepine
Oxcarbazepime
Oxcarbazepina
Oxcarbazepina [INN-Spanish]
oxcarbazepine
Oxcarbazepine
OXCARBAZEPINE
Oxcarbazepine (USAN/INN)
Oxcarbazepine [INN]
Oxcarbazepinum
Oxcarbazepinum [INN-Latin]
S1391_Selleck
SAM001246754
SMR000048684
SPBio_000345
Spectrum_001675
SPECTRUM1504243
Spectrum2_000483
Spectrum3_001669
Spectrum4_000634
Spectrum5_001869
SPN-804
STK594696
Timox
Trileptal
Trileptal (TN)
UNII-VZI5B1W380
ZINC00004724
|
|
43 |
|
Carbamazepine |
Approved, Investigational |
Phase 1, Phase 2 |
|
298-46-4 |
2554 |
Synonyms:
298-46-4
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz(b,F)azepine
5-carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
benzo[b][1]benzazepine-11-carboxamide
BIDD:GT0479
BIM-0050280.0001
Bio-0751
Bipotrol
Biston
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
carbamazepine
Carbamazepine
Carbamazépine
Carbamazepine (JP15/USP/INN)
carbamazepine (Tegretol)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepine acetate
Carbamazepine anhydrous
Carbamazepine dihydrate
Carbamazepine hydrochloride
Carbamazepine L-tartrate (4:1)
Carbamazepine phosphate
Carbamazepine sulfate (2:1)
CARBAMAZEPINE, U.S.P.
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
ChemDiv1_018966
CID2554
CPD001227191
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
Equetro
|
Equetro (TN)
EU-0100292
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
Karbamazepin
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Lexin
Lopac0_000292
Lopac-C-4024
LS-60362
MLS000069652
MLS001055475
MLS001074172
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
nchem.859-comp7
Neurotol
Neurotop retard
NINDS_000388
Novo-Carbamaz
NSC 169864
NSC169864
Nu-Carbamazepine
Oprea1_790775
Prestwick_104
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
S1693_Selleck
SAM002264603
Sirtal
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
Spectrum_000096
SPECTRUM1500159
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Stazepin
Stazepine
STK177357
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
|
|
44 |
|
Primidone |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
125-33-7 |
4909 |
Synonyms:
125-33-7
2-deoxyphenobarbital
2-Deoxyphenobarbital
2-Desoxyphenobarbital
4,4'-(Hexamethylenedioxy)dibenzamidine
5-24-08-00102 (Beilstein Handbook Reference)
5-Aethyl-5-phenyl-hexahydropyrimidin-4,6-dion
5-Aethyl-5-phenyl-hexahydropyrimidin-4,6-dion [German]
5-ethyl-5-phenyl-1,3-diazinane-4,6-dione
5-ethyl-5-phenyldihydropyrimidine-4,6(1H,5H)-dione
5-Ethyl-5-phenylhexahydropyrimidine-4,6-dione
5-Ethyldihydro-5-phenyl-4,6(1H,5H)-pyrimidinedione
5-ethylhe xahydro-4,6-dioxo-5-phenylpyrimidine
5-Ethylhexahydro-4,6-dioxo-5-phenylpyrimidine
5-Ethylhexahydro-5-phenylpyrimidine-4,6-dione
5-Phenyl-5-aethylhexahydropyrimidindion-(4,6)
5-Phenyl-5-aethylhexahydropyrimidindion-(4,6) [German]
5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione
5-Phenyl-5-ethyl-Hexahydropyrimidine-4,6-dione
AB00052079
AC1L1J82
AKOS003368409
apo-Primidone
Apo-Primidone
Apotex brand OF primidone
Apotex Brand of Primidone
Astra brand OF primidone
Astra Brand of Primidone
AstraZeneca brand OF primidone
AstraZeneca Brand of Primidone
BIDD:GT0319
Biomol-NT_000261
BPBio1_000859
BPBio1_000954
BRD-K32247306-001-05-4
BRN 0218034
BSPBio_000866
BSPBio_002225
C07371
CAS-125-33-7
CCRIS 54
CHEMBL856
CID4909
CPD000058501
Cyral
D00474
D011324
DB00794
Desitin brand OF primidone
Desitin Brand of Primidone
Desoxyphenobarbital
Desoxyphenobarbitone
DivK1c_000324
Draxis brand OF primidone
Draxis Brand of Primidone
EINECS 204-737-0
EU-0101021
Hexadiona
hexamidine (the antispasmodic)
Hexamidine (the antispasmodic)
Hexamidine(the antispasmodic)
HMS1570L08
HMS1920J20
HMS2092A21
HMS501A06
Holsten brand OF primidone
Holsten Brand of Primidone
HSDB 3169
I06-0632
IDI1_000324
KBio1_000324
KBio2_001312
KBio2_003880
KBio2_006448
KBio3_001725
KBioGR_000969
KBioSS_001312
Lepimidin
Lepsiral
Liskantin
Lopac0_001021
Lopac-P-7295
LS-48
Majsolin
Medi-Pets
Midone
Milepsin
Misodine
|
Misolyne
Mizodin
Mizolin
MLS000028593
MLS001055411
MLS001074125
MolPort-001-783-659
Myidone
Mylepsin
Mylepsinum
Mysedon
Mysoline
Mysoline (TN)
NCGC00015834-01
NCGC00015834-02
NCGC00015834-07
NCGC00015834-14
NCGC00016377-01
NCGC00023254-02
NCGC00023254-04
NCGC00023254-05
NCGC00023254-06
NCGC00023254-07
NCGC00023254-08
NCGC00023254-09
NCGC00023254-10
NCI-C56360
Neurosyn
NINDS_000324
NSC 41701
NSC41701
P 7295
P7295_FLUKA
P7295_SIGMA
Pms Primidone
Prestwick0_000933
Prestwick1_000933
Prestwick2_000933
Prestwick3_000933
Prilepsin
Primacione
Primaclone
Primacone
Primakton
Primidon
Primidon holsten
Primidon Holsten
Primidona
Primidona [INN-Spanish]
primidone
Primidone
Primidone (JP15/USP/INN)
Primidone (primaclone)
Primidone [USAN:INN:BAN:JAN]
Primidone Methanol Solution
Primidonum
Primidonum [INN-Latin]
Primoline
Prysoline
Pyrimidone "Medi-pets"
Pyrimidone Medi-pets
Resimatil
Roe 101
S1965_Selleck
SAM002554925
Sanofi-synthelabo brand OF primidone
Sanofi-Synthelabo Brand of Primidone
Sertan
SMP1_000135
SMR000058501
SPBio_001325
SPBio_003035
Spectrum_000832
SPECTRUM1500501
Spectrum2_001293
Spectrum3_000553
Spectrum4_000485
Spectrum5_001144
ST076725
Tocris-0830
UNII-13AFD7670Q
WLN: T6MV DVMTJ C2 CR
Xcel brand OF primidone
Xcel Brand of Primidone
Zeneca brand OF primidone
Zeneca Brand of Primidone
ZINC00001979
|
|
45 |
|
Dasatinib |
Approved, Investigational |
Phase 2 |
|
302962-49-8 |
3062316 |
Synonyms:
(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
(18F)-N-(2-chloro-6-Methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
1N1
2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide
302962-49-8
AC1MI3ET
AC1Q2P0C
AmbotzLS-1203
anh. dasatinib
Anh. dasatinib
Anhydrous dasatinib
BCB03_000715
BMS 354825
BMS dasatinib
BMS Dasatinib
BMS354825
BMS-354825
BMS-354825, Sprycel, BMS354825, Dasatinib
C488369
CHEBI:49375
CHEMBL1421
CID3062316
D03658
dasatinib
Dasatinib
Dasatinib (anh.)
dasatinib (anhydrous)
Dasatinib (USAN)
Dasatinib [USAN]
Dasatinib anhydrous
Dasatinib, BMS 354825
|
dasatinibum
Dasatinibum
DB01254
EC-000.2122
EN002710
FT-0084503
I14-1972
Kinome_3650
LS-186641
LS-187028
LS-187773
MolPort-003-846-143
N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide
N-(2-chloro-6-METHYLPHENYL)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide
N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide
N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
N-(2-chloro-6-Methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
NCGC00181129-01
nchembio.117-comp11
nchembio.162-comp4
nchembio.332-comp1
NSC732517
NSC-732517
S1021_Selleck
Sprycel
SPRYCEL (TN)
Spyrcel
UNII-X78UG0A0RN
|
|
46 |
|
Topotecan |
Approved, Investigational |
Phase 2 |
|
123948-87-8, 119413-54-6 |
60700 |
Synonyms:
(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione
(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE
123948-87-8
9 Dimethylaminomethyl 10 hydroxycamptothecin
9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin
9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin
9-Dimethylaminomethyl-10-hydroxycamptothecin
AC-11592
AC1L1TQZ
AC1Q6APZ
BSPBio_002348
C11158
C23H23N3O5
CCRIS 8163
CHEBI:107501
CHEBI:46035
CHEMBL84
CID60700
D08618
DB01030
HMS2090B20
HSCI1_000228
Hycamptamine
Hycamptin
Hycamtamine
Hycamtin
Hycamtin (TN)
Hydrochloride, nogitecan
Hydrochloride, topotecan
LS-127395
MLS000759456
NCGC00178695-01
NChemBio.2007.10-comp24
|
NCI60_004771
NCIStruc1_001659
NCIStruc2_001796
Nogitecan hydrochloride
NSC609699
SK And F 104864 a
SK And F104864a
SK And F-104864-a
SK&F-104864-A
SKF 104864
SKF-104864-A
SKF-S 104864
SmithKline beecham brand OF topotecan hydrochloride
SMP2_000312
SMP2_000327
SMR000466344
TOPO
topotecan
Topotecan
Topotecan (BAN)
Topotecan [INN:BAN]
Topotecan Hcl
Topotecan hydrochloride
Topotecan Hydrochloride
Topotecan lactone
Topotecan Lactone
Topotecan monohydrochloride, (S)-isomer
Topotecan Monohydrochloride, (S)-Isomer
TOPOTECAN, HYCAMTIN
Topotecane
Topotecane [INN-French]
Topotecanum
Topotecanum [INN-Latin]
TPT
TTC
UNII-7M7YKX2N15
|
|
47 |
|
Mercaptopurine |
Approved |
Phase 2 |
|
50-44-2 |
667490 |
Synonyms:
1,7-dihydro-6H-Purine-6-thione
1,7-Dihydro-6H-purine-6-thione
1,9-dihydro-6H-purine-6-thione
3,7-dihydropurine-6-thione
39454-94-9
3H-Purine-6-thiol
50-44-2
5759-99-9
5818-33-7
5818-60-0
6 Mercaptopurine
6 Mercaptopurine monohydrate
6 Mercaptopurine Monohydrate
6 MP
6 Thiohypoxanthine
6 Thiopurine
6112-76-1
6112-76-1 (monohydrate)
63810_FLUKA
6-Mercaptopurin
6-Mercaptopurine
6-Mercaptopurine monohydrate
6-MERCAPTOPURINE MONOHYDRATE
6-Merkaptopurin
6-Merkaptopurin [Czech]
6-MP
6-Purinethiol
6-Thiohypoxanthine
6-Thiopurine
6-Thioxopurine
7H-purine-6-thiol
7-Mercapto-1,3,4,6-tetrazaindene
9H-Purin-6-yl hydrosulfide
9H-Purine-6(1H)-thione
AC-11464
AC1LDI73
AG-670/31547064
AKOS000170222
AKOS000275858
Ambap50-44-2
BB_SC-0064
BSPBio_001981
BW 57 323H
C01756
C02380
C5H4N4S
CCRIS 2761
CHEBI:2208
CHEBI:50667
CHEMBL1425
CID667490
cMAP_000033
CPD000544948
D015122
D04931
DB01033
DivK1c_000493
EINECS 200-037-4
F3329-0452
FT-0083571
glaxo Wellcome brand OF 6 mercaptopurine
Glaxo Wellcome Brand of 6 Mercaptopurine
glaxo Wellcome brand OF 6-mercaptopurine
Glaxo Wellcome Brand of 6-Mercaptopurine
GlaxoSmithKline brand OF 6 mercaptopurine
GlaxoSmithKline Brand of 6 Mercaptopurine
GlaxoSmithKline brand OF 6-mercaptopurine
GlaxoSmithKline Brand of 6-Mercaptopurine
HMS1920L07
HMS2091B20
HMS501I15
HSDB 3235
I14-1716
IDI1_000493
Ismipur
KBio1_000493
KBio2_001401
KBio2_002363
KBio2_003969
KBio2_004931
KBio2_006537
KBio2_007499
KBio3_001481
|
KBio3_002842
KBioGR_001493
KBioGR_002363
KBioSS_001401
KBioSS_002366
Leukerin
Leukerin, 99% - Carc
Leupu rin
Leupurin
LS-141
M0063
Mercaleukim
Mercaleukin
Mercaptopurin
Mercaptopurin [German]
Mercaptopurina
Mercaptopurina [INN-Spanish]
Mercaptopurina wellcome
Mercaptopurina Wellcome
mercaptopurine
Mercaptopurine
Mercaptopurine (anhydrous)
Mercaptopurine (INN)
Mercaptopurine (VAN)
Mercaptopurine anhydrous
Mercaptopurine monohydrate
Mercaptopurine Monohydrate
Mercaptopurinum
Mercaptopurinum [INN-Latin]
Mercapurin
Merkaptopuryna
Merkaptopuryna [Polish]
Mern
MLS001066623
MLS001304020
MLS001304953
MolPort-001-783-696
MolPort-001-815-626
MolPort-003-846-751
MP
NCGC00094717-01
NCGC00094717-02
NCGC00094717-03
NCI60_041653
NCI-C04886
NCIMech_000025
NINDS_000493
NSC 755
NSC755
NSC-755
PM6
Puri nethol
Puri Nethol
Purimethol
purine antimetabolite: inhibits nucleic acid replication
Purine-6(1H)-thione
Purine-6-thiol
Purinethiol
Purinethol
Puri-nethol
Puri-Nethol
Purinethol (TN)
Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine
S1305_Selleck
SAM002589937
SMR000544948
SPBio_000219
Spectrum_000921
SPECTRUM1500387
Spectrum2_000060
Spectrum3_000491
Spectrum4_000857
Spectrum5_000950
STK727062
Thiopurine
U-4748
UNII-PKK6MUZ20G
Wellcome brand OF 6 mercaptopurine
Wellcome Brand of 6 Mercaptopurine
Wellcome brand OF 6-mercaptopurine
Wellcome Brand of 6-Mercaptopurine
WLN: T56 BM DN FN HNJ ISH
Xaluprine
|
|
48 |
|
Streptozocin |
Approved, Investigational |
Phase 2 |
|
18883-66-4 |
29327 |
Synonyms:
18883-66-4
1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose
2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose
2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose
2-Deoxy-2[[(methylnitrosoamino)-carbonyl]amino]-D-glucopyranose
2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose
AB00513906
AC1L1H7V
alkylating agent
Ambap18883-66-4
BCBcMAP01_000142
binds to DNA
BPBio1_000754
BSPBio_000684
BSPBio_002734
C07313
CHEBI:9288
CHEMBL1603
CID29327
D05932
DB00428
D-Glucose, 2-deoxy-2-(((methylnitrosoamino)carbonyl)amino)- (9CI)
DivK1c_000531
Estreptozocina
HMS1921A07
HMS2092I09
HMS501K13
IDI1_000531
KBio1_000531
KBio2_001440
KBio2_004008
KBio2_006576
KBio3_001954
KBioGR_001768
KBioSS_001440
MolPort-003-665-493
N-(Methylnitrosocarbamoyl)-alpha-D-glucosamine
NCGC00178500-01
NCGC00178500-02
|
N-D-Glucosyl-(2)-n'
N-D-Glucosyl-(2)-N'-nitrosomethylharnstoff
N-D-Glucosyl-(2)-n'-nitrosomethylurea
N-D-Glucosyl-(2)-N'-nitrosomethylurea
NINDS_000531
-nitrosomethylharnstoff
Prestwick3_000732
S0130_SIAL
S0130_SIGMA
S1312_Selleck
SMP1_000282
SPBio_000243
Spectrum_000960
SPECTRUM1500543
Spectrum2_000062
Spectrum3_001087
Spectrum4_001244
Spectrum5_001047
streptozocin
Streptozocin
Streptozocin (USAN/INN)
Streptozocin teva brand
Streptozocin, Zanosar, STZ,Streptozotocin
Streptozocine
Streptozocine [INN-French]
Streptozocinium
Streptozocinium [Latin]
Streptozocinum
Streptozocinum [INN-Latin]
streptozosin
Streptozotocin
STREPTOZOTOCIN
Streptozotocine
STRZ
Teva brand OF streptozocin
UNII-5W494URQ81
Zanosar
Zanosar (TN)
ZINC03977737
|
|
49 |
|
Aldesleukin |
Approved |
Phase 2 |
|
85898-30-2, 110942-02-4 |
|
Synonyms:
125-L-serine-2-133-interleukin 2 (human reduced)
Aldesleukina
Interleukin-2 aldesleukin
|
Interleukin-2(2-133),125-ser
Recombinant interleukin-2 human
|
|
50 |
|
Panobinostat |
Approved, Investigational |
Phase 1, Phase 2 |
|
404950-80-7 |
6918837 |
Synonyms:
(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide
(E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE
(E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide
404950-80-7
AC1OCFY8
AKOS005146046
C496932
CHEMBL483254
CID6918837
EC-000.2287
Faridak
FT-0083488
LBH 589
|
LBH589
LBH-589
LBH-589B
MolPort-005-933-338
nchembio.313-comp11
NVP-LBH589
NVP-LBH-589
Panobinostat
Panobinostat, NVP-LBH589, LBH589
Panobinostatum
S1030_Selleck
ZINC22010649
|
|
Interventional clinical trials:
(show top 50)
(show all 174)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA |
Completed |
NCT00002840 |
Phase 3 |
lomustine;procarbazine hydrochloride;vincristine sulfate |
2 |
Phase III Intergroup Randomized Comparison of Radiation Alone vs. Pre-Radiation Chemotherapy for Pure and Mixed Anaplastic Oligodendrogliomas |
Completed |
NCT00002569 |
Phase 3 |
lomustine;procarbazine hydrochloride;vincristine sulfate |
3 |
Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain |
Completed |
NCT00369785 |
Phase 3 |
donepezil hydrochloride;Placebo |
4 |
A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain |
Completed |
NCT00538850 |
Phase 3 |
Fentanyl sublingual spray;Placebo |
5 |
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma |
Recruiting |
NCT00887146 |
Phase 3 |
concomitant temozolomide (TMZ);procarbazine;adjuvant temozolomide (TMZ);CCNU;vincristine |
6 |
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. |
Active, not recruiting |
NCT00626990 |
Phase 3 |
temozolomide |
7 |
A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy |
Terminated |
NCT00031798 |
Phase 3 |
methylphenidate hydrochloride |
8 |
Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk |
Terminated |
NCT01132547 |
Phase 3 |
cyproheptadine hydrochloride |
9 |
Phase III Randomized Evaluation of 13-Cis-Retinoic Acid (cRA) Plus Procarbazine Versus Procarbazine Alone in the Treatment of Patients With Recurrent Primary Malignant Gliomas |
Withdrawn |
NCT00003564 |
Phase 3 |
Isotretinoin;Procarbazine Hydrochloride |
10 |
Phase I/II Clinical Trial of the Safety, Tolerability, and Anti-tumor Efficacy of the IGF-1R Inhibitor, AXL1717 (Picropodophyllin), in the Treatment of Recurrent Malignant Astrocytomas |
Unknown status |
NCT01721577 |
Phase 1, Phase 2 |
AXL1717 |
11 |
A Phase II Study of Temozolomide in the Treatment of Recurrent Malignant Gliomas |
Unknown status |
NCT00004204 |
Phase 2 |
temozolomide |
12 |
Phase I/II Study of Intratumoral Injection of DTI-015 Prior to Tumor Resection in Patients With Recurrent Malignant Glioma or Metastatic Neoplasm to Brain |
Unknown status |
NCT00009854 |
Phase 1, Phase 2 |
carmustine in ethanol |
13 |
Pilot Study to Determine Therapeutic Response of Oral Capecitabine (Xeloda) in Recurrent High Grade Gliomas (HGGs) by Establishing the Radiographic Response Rate Using Modified Macdonald Criteria |
Completed |
NCT00717197 |
Phase 2 |
Capecitabine |
14 |
Phase II Trial of Bevacizumab Plus Erlotinib for Patients With Recurrent Malignant Glioma |
Completed |
NCT00671970 |
Phase 2 |
Bevacizumab and Erlotinib |
15 |
Phase II Treatment of Adults With Newly Diagnosed, Progressive or Recurrent Primary Malignant Anaplastic Oligodendroglioma With Temodal |
Completed |
NCT00003465 |
Phase 2 |
temozolomide |
16 |
The Efficacy and Safety of Temozolomide in Patients With Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: a Multicenter, Single-arm, Phase II Trial |
Completed |
NCT01847235 |
Phase 2 |
Temozolomide |
17 |
Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma |
Completed |
NCT00400816 |
Phase 2 |
temozolomide |
18 |
Open Label Phase II Study On STI571 (Glivec) Administered As A Daily Oral Treatment In Gliomas |
Completed |
NCT00039364 |
Phase 2 |
imatinib mesylate |
19 |
A Phase II Study of Topotecan in Patients With Anaplastic Oligodendroglioma or Anaplastic Mixed Oligoastrocytoma |
Completed |
NCT00003372 |
Phase 2 |
topotecan hydrochloride |
20 |
Phase II Evaluation of Fenretinide NSC (374551) as a Single Agent in the Treatment of Adult Patients With Recurrent Malignant Glioma |
Completed |
NCT00006080 |
Phase 2 |
fenretinide |
21 |
Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma |
Completed |
NCT00362570 |
Phase 2 |
Temozolomide |
22 |
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms |
Completed |
NCT00004688 |
Phase 2 |
carmustine;mercaptopurine;streptozocin |
23 |
A Phase I/II Study of Col-3 Administered on a Continuous Daily Oral Schedule in Patients With Recurrent High-Grade Astrocytoma |
Completed |
NCT00004147 |
Phase 1, Phase 2 |
incyclinide |
24 |
A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas |
Completed |
NCT00012038 |
Phase 1, Phase 2 |
irofulven |
25 |
A Phase II Trial of Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma |
Completed |
NCT00003101 |
Phase 2 |
busulfan;lomustine;procarbazine hydrochloride;thiotepa;vincristine sulfate |
26 |
A Phase II Study of Temozolomide (SCH 52365, Temodal(R)) for the Treatment of Recurrent Malignant Glioma |
Completed |
NCT00004113 |
Phase 2 |
temozolomide |
27 |
A Multi-Center, Open-Label Clinical Study to Evaluate the Safety and Performance of the Proxima GliaSite RTS, a Radiation Delivery System, in Patients With Recurrent Malignant Brain Tumors Undergoing Surgical Resection |
Completed |
NCT00003574 |
Phase 2 |
|
28 |
ANALYSIS OF THE EFFICACY OF SURAMIN IN RECURRENT MALIGNANT PRIMARY BRAIN TUMORS |
Completed |
NCT00002639 |
Phase 2 |
chemotherapy;suramin |
29 |
A Phase II Trial of Poly ICLC in Patients With Recurrent Anaplastic Glioma |
Completed |
NCT00058123 |
Phase 2 |
poly ICLC |
30 |
Bevacizumab in Combination With Irinotecan for Malignant Gliomas |
Completed |
NCT00268359 |
Phase 2 |
irinotecan hydrochloride |
31 |
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma |
Completed |
NCT00498927 |
Phase 2 |
temozolomide |
32 |
Phase I/II Study of LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma |
Completed |
NCT00859222 |
Phase 1, Phase 2 |
LBH589;bevacizumab |
33 |
A Phase II Trial Of Thalidomide And Procarbazine In Adults With Recurrent/Progressive Gliomas |
Completed |
NCT00079092 |
Phase 2 |
procarbazine hydrochloride;thalidomide |
34 |
A Phase I/II Trial of EMD 121974 for Treatment of Patients With Recurrent Anaplastic Gliomas |
Completed |
NCT00006093 |
Phase 1, Phase 2 |
cilengitide |
35 |
A Phase I/II Study of Oral Procarbazine in the Treatment of Recurrent High Grade Astrocytomas |
Completed |
NCT00004004 |
Phase 1, Phase 2 |
procarbazine hydrochloride |
36 |
A Phase II Trial Of Pre-Irradiation And Concurrent Temozolomide In Patients With Newly Diagnosed Anaplastic Oligodendrogliomas And Mixed Anaplastic Oligoastrocytomas |
Completed |
NCT00033280 |
Phase 2 |
temozolomide |
37 |
Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors |
Completed |
NCT00003458 |
Phase 2 |
Antineoplaston therapy (Atengenal + Astugenal) |
38 |
PHASE I STUDY OF ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT BRAIN TUMORS |
Completed |
NCT00002752 |
Phase 1, Phase 2 |
|
39 |
A Phase II Trial Of Talampanel In Patients With Recurrent High-Grade Gliomas |
Completed |
NCT00064363 |
Phase 2 |
talampanel |
40 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
Completed |
NCT00049127 |
Phase 1, Phase 2 |
Imatinib Mesylate |
41 |
Trial Of Oral Thalidomide, Celecoxib, Etoposide And Cyclophosphamide In Adult Patients With Relapsed Or Progressive Malignant Gliomas |
Completed |
NCT00047281 |
Phase 2 |
celecoxib;cyclophosphamide;etoposide;thalidomide |
42 |
Levetiracetam and Pregabalin for Monotherapy in Patients With Brain Tumors and Seizures. A Phase II Randomized Study. |
Completed |
NCT00629889 |
Phase 2 |
levetiracetam;pregabalin |
43 |
Improved Characterization of Brain Tumors By MRI and MRS |
Completed |
NCT00274755 |
Phase 2 |
chemotherapy |
44 |
Phase II Study of Bevacizumab (Avastin) and BCNU for Treatment of Relapsed, High Grade Gliomas |
Completed |
NCT00795665 |
Phase 2 |
bevacizumab;carmustine |
45 |
A Phase 2, Open-label, Proof-of-concept Study to Assess the Ability to Detect Tumours and Angiogenesis Via the Expression of ανβ3/5 Integrin Receptors by [18F]AH-111585 PET Imaging |
Completed |
NCT00565721 |
Phase 2 |
Fluciclatide Injection - (AH111585 (F18)) |
46 |
A Pilot Study of Tamoxifen, Carboplatin and Topotecan in the Treatment of Recurrent or Refractory Primary Brain or Spinal Cord Tumors or Metastatic Epithelial Cancers With Central Nervous System Metastases |
Completed |
NCT00541138 |
Phase 2 |
carboplatin;tamoxifen citrate;topotecan hydrochloride |
47 |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Bevacizumab in Combination With Irinotecan for Malignant Gliomas |
Completed |
NCT00352521 |
Phase 2 |
bevacizumab;irinotecan |
48 |
A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue |
Completed |
NCT01032200 |
Phase 2 |
Armodafinil |
49 |
Oral ST1481 in Adults With Malignant Glioma: A Phase I-II Clinical Trial |
Completed |
NCT00087061 |
Phase 1, Phase 2 |
gimatecan |
50 |
CAMP 004A - Phase 2 Study Of Intensive Chemotherapy (BET) For Selected Categories Of Malignant Central Nervous System Tumor |
Completed |
NCT00007982 |
Phase 2 |
carmustine;cisplatin;cyclophosphamide;etoposide;thiotepa |
|